Marine Lingrand

Ms. Marine Lingrand

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2022 in Science Immunology
Verified
Journal Article
Closed access
DMDan Moldoveanu
Dan Moldoveanu
LRLeeAnn Ramsay
LeeAnn Ramsay
MLMathieu Lajoie
Mathieu Lajoie
LALuke Anderson-Trocme
Luke Anderson-Trocme
MLMarine Lingrand
Marine Lingrand
IWIan R. Watson
Ian R. Watson
Melanoma is an immunogenic cancer with a high response rate to immune checkpoint inhibitors (ICIs). It harbors a high mutation burden compared with other cancers and, as a result, has abundant tumor-infiltrating lymphocytes (TILs) within its microenvironment. However, understanding the complex interplay between the stroma, tumor cells, and distinct TIL subsets remains a substantial challenge in immune oncology. To properly study this interplay, quantifying spatial relationships of multiple cell types within the tumor microenvironment is crucial. To address this, we used cytometry time-of-flight (CyTOF) imaging mass cytometry (IMC) to simultaneously quantify the expression of 35 protein markers, characterizing the microenvironment of 5 benign nevi and 67 melanomas. We profiled more than 220,000 individual cells to identify melanoma, lymphocyte subsets, macrophage/monocyte, and stromal cell populations, allowing for in-depth spatial quantification of the melanoma microenvironment. We found that within pretreatment melanomas, the abundance of proliferating antigen-experienced cytotoxic T cells (CD8 + CD45RO + Ki67 + ) and the proximity of antigen-experienced cytotoxic T cells to melanoma cells were associated with positive response to ICIs. Our study highlights the potential of multiplexed single-cell technology to quantify spatial cell-cell interactions within the tumor microenvironment to understand immune therapy responses.

Verified
Journal Article
Open access
PDF file
ZGZhiqiang Guo
Zhiqiang Guo
KBKarl-Frederik Bergeron
Karl-Frederik Bergeron
MLMarine Lingrand
Marine Lingrand
Catherine MounierCatherine Mounier
Catherine Mounier
Monounsaturated fatty acids (MUFAs) have been the subject of extensive research in the field of cancer due to their potential role in its prevention and treatment. MUFAs can be consumed through the diet or endogenously biosynthesized. Stearoyl-CoA desaturases (SCDs) are key enzymes involved in the endogenous synthesis of MUFAs, and their expression and activity have been found to be increased in various types of cancer. In addition, diets rich in MUFAs have been associated with cancer risk in epidemiological studies for certain types of carcinomas. This review provides an overview of the state-of-the-art literature on the associations between MUFA metabolism and cancer development and progression from human, animal, and cellular studies. We discuss the impact of MUFAs on cancer development, including their effects on cancer cell growth, migration, survival, and cell signaling pathways, to provide new insights on the role of MUFAs in cancer biology.

29 January 2020 in Breast Cancer
Verified
Journal Article
Closed access
PDF file
MLMarine Lingrand
Marine Lingrand
SLSimon Lalonde
Simon Lalonde
AJAntoine Jutras-Carignan
Antoine Jutras-Carignan
KBKarl-Frederik Bergeron
Karl-Frederik Bergeron
EREric Rassart
Eric Rassart
Catherine MounierCatherine Mounier
Catherine Mounier

22 June 2020 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
RARached Alkallas
Rached Alkallas
MLMathieu Lajoie
Mathieu Lajoie
DMDan Moldoveanu
Dan Moldoveanu
KHKaren Vo Hoang
Karen Vo Hoang
PLPhilippe Lefrançois
Philippe Lefrançois
IWIan R. Watson
Ian R. Watson